{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:17:25Z","timestamp":1786483045074,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":34,"publisher":"Springer US","isbn-type":[{"value":"9781071631744","type":"print"},{"value":"9781071631751","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3175-1_9","type":"book-chapter","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:02:13Z","timestamp":1684479733000},"page":"163-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Performance and Interpretation of Clot Waveform Analysis"],"prefix":"10.1007","author":[{"given":"Maria Filomena","family":"Ruberto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Barcellona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0029-1214144","volume":"35","author":"G Lippi","year":"2009","unstructured":"Lippi G, Favaloro EJ, Franchini M, Guidi GC (2009) Milestones and perspectives in coagulation and hemostasis. Semin Thromb Hemost 35:9\u201322","journal-title":"Semin Thromb Hemost"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1043454206298693","volume":"24","author":"JP Riddel Jr","year":"2007","unstructured":"Riddel JP Jr, Aouizerat BE, Miaskowski C, Lillicrap DP (2007) Theories of blood coagulation. J Pediatr Oncol Nurs 24:123\u2013131","journal-title":"J Pediatr Oncol Nurs"},{"key":"9_CR3","first-page":"11","volume":"5","author":"OD Ratnoff","year":"1968","unstructured":"Ratnoff OD (1968) An approach to the diagnosis of disorders of hemostasis. Mod Treat 5:11\u201338","journal-title":"Mod Treat"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2141.2009.07833.x","volume":"147","author":"A Tripodi","year":"2009","unstructured":"Tripodi A, Chantarangkul V, Mannucci PM (2009) Acquired coagulation disorders: revisited using global coagulation\/anticoagulation testing. Br J Haematol 147:77\u201382","journal-title":"Br J Haematol"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1182\/blood-2004-03-1042","volume":"104","author":"A Tripodi","year":"2004","unstructured":"Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM (2004) A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104:3631\u20133634","journal-title":"Blood"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0038-1677018","volume":"45","author":"EJ Favaloro","year":"2019","unstructured":"Favaloro EJ, Kershaw G, Mohammed S, Lippi G (2019) How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying Normal reference intervals and assessing APTT reagents for sensitivity to heparin, lupus anticoagulant, and clotting factors. Semin Thromb Hemost 45:22\u201335","journal-title":"Semin Thromb Hemost"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1055\/s-0038-1657690","volume":"78","author":"PJ Braun","year":"1997","unstructured":"Braun PJ, Givens TB, Stead AG, Beck LR, Gooch SA, Swan RJ, Fischer TJ (1997) Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemost 78:1079\u20131087","journal-title":"Thromb Haemost"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/jth.12287","volume":"11","author":"M Shima","year":"2013","unstructured":"Shima M, Thachil J, Nair SC, Srivastava A (2013) Scientific and standardization committee. Towards standardization of clot waveform analysis and recommendations for its clinical applications. J Thromb Haemost 11:1417\u20131420","journal-title":"J Thromb Haemost"},{"key":"9_CR9","doi-asserted-by":"crossref","unstructured":"Matsumoto T, Shima M, Takeyama M, Yoshida K, Tanaka I, Sakurai Y, Giles AR, Yoshioka A (2006) The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost 4:377\u2013384","DOI":"10.1111\/j.1538-7836.2006.01730.x"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1751-553X.2010.01248.x","volume":"33","author":"C Solano","year":"2011","unstructured":"Solano C, Zerafa P, Bird R (2011) A study of atypical APTT derivative curves on the ACL TOP coagulation analyser. Int J Lab Hematol 33:67\u201378","journal-title":"Int J Lab Hematol"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/MBC.0000000000000436","volume":"27","author":"N Tokunaga","year":"2016","unstructured":"Tokunaga N, Inoue C, Sakata T, Kagawa K, Abe M, Takamatsu N, Nakao T, Doi T (2016) Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies. Blood Coagul Fibrinolysis 27:474\u2013476","journal-title":"Blood Coagul Fibrinolysis"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1055\/s-0039-1691752","volume":"39","author":"D Barcellona","year":"2019","unstructured":"Barcellona D, Favuzzi G, Vannini ML, Piras SM, Ruberto MF, Grandone E, Marongiu F (2019) A Sardinian family with factor XI deficiency. Hamostaseologie 39:398\u2013403","journal-title":"Hamostaseologie"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"107602962097881","DOI":"10.1177\/1076029620978810","volume":"26","author":"D Shimomura","year":"2020","unstructured":"Shimomura D, Matsumoto T, Sugimoto K, Takata T, Kouno A, Shimada M, Matsuo S, Kamioka M (2020) The first-derivative curve of the coagulation waveform reveals the cause of aPTT prolongation. Clin Appl Thromb Hemost 26:1076029620978810","journal-title":"Clin Appl Thromb Hemost"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1055\/s-0037-1613023","volume":"87","author":"M Shima","year":"2002","unstructured":"Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A (2002) The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost 87:436\u2013441","journal-title":"Thromb Haemost"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2257.2002.00457.x","volume":"24","author":"CH Toh","year":"2002","unstructured":"Toh CH, Giles AR (2002) Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation (DIC). Clin Lab Haematol 24:321\u2013327","journal-title":"Clin Lab Haematol"},{"key":"9_CR16","doi-asserted-by":"crossref","unstructured":"Dempfle CE, Lorenz S, Smolinski M, Wurst M, West S, Houdijk WP, Quintel M, Borggrefe M (2004) Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit. Crit Care Med 32:520\u2013524","DOI":"10.1097\/01.CCM.0000110678.52863.F3"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1053\/j.seminhematol.2003.11.021","volume":"41","author":"M Shima","year":"2004","unstructured":"Shima M (2004) Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis. Semin Hematol 41:125\u2013131","journal-title":"Semin Hematol"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1398-9995.2010.02506.x","volume":"66","author":"T Takeda","year":"2011","unstructured":"Takeda T, Sakurai Y, Takahagi S, Kato J, Yoshida K, Yoshioka A, Hide M, Shima M (2011) Increase of coagulation potential in chronic spontaneous urticaria. Allergy 66:428\u2013433","journal-title":"Allergy"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/ijlh.12635","volume":"39","author":"MF Ruberto","year":"2017","unstructured":"Ruberto MF, Sorbello O, Civolani A, Barcellona D, Demelia L, Marongiu F (2017) Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena. Int J Lab Hematol 39:369\u2013374","journal-title":"Int J Lab Hematol"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1515\/cclm-2017-0678","volume":"56","author":"MF Ruberto","year":"2018","unstructured":"Ruberto MF, Marongiu F, Mandas A, Mameli A, Porru M, Cianchetti E, Barcellona D (2018) The venous thromboembolic risk and the clot wave analysis: a useful relationship? Clin Chem Lab Med 56:448\u2013453","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"9_CR21","doi-asserted-by":"publisher","first-page":"jphr.2021.2358","DOI":"10.4081\/jphr.2021.2358","volume":"10","author":"F Marongiu","year":"2021","unstructured":"Marongiu F, Ntoukas DM, Barberini L, Ruberto MF, Piras MS, Conti M, Di Martino ML, Mura M, Marongiu S, Vannini ML, Lillu M, Piras M, Fanni D, Fenu L, Porcu C, Barcellona D, Faa G, Congiu T (2021) Clot characterization by multidisciplinary approach: biochemical and imaging parameters in a hypocoagulative setting. A pilot study. J Public Health Res 10(4):jphr.2021.2358","journal-title":"J Public Health Res"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/ijlh.12934","volume":"41","author":"MF Ruberto","year":"2019","unstructured":"Ruberto MF, Marongiu F, Sorbello O, Civolani A, Demelia L, Barcellona D (2019) Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? Int J Lab Hematol 41:118\u2013123","journal-title":"Int J Lab Hematol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1111\/ijlh.12769","volume":"40","author":"MF Ruberto","year":"2018","unstructured":"Ruberto MF, Marongiu F, Barcellona D (2018) Comparison of prothrombin time INR and clot waveform analysis performed with 129-mmol\/L and 105-mmol\/L citrate tubes. Int J Lab Hematol 40:e15\u2013e16","journal-title":"Int J Lab Hematol"},{"key":"9_CR24","first-page":"113","volume":"214","author":"HR Gralnick","year":"1987","unstructured":"Gralnick HR, Wilson OJ (1987) Cold-promoted activation of factor VII and shortening of the prothrombin time. Adv Exp Med Biol 214:113\u2013129","journal-title":"Adv Exp Med Biol"},{"key":"9_CR25","unstructured":"Doubleday K, Kumnick S Clot signature curves and the ACL advance\u2122. Instrumentation Laboratory"},{"key":"9_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.258","volume":"4","author":"K Kanouchi","year":"2021","unstructured":"Kanouchi K, Narimatsu H, Shirata T, Morikane K (2021) Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: a retrospective analysis. Health Sci Rep 4:e258","journal-title":"Health Sci Rep"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score. J Thromb Haemost 8:2450\u20132457","journal-title":"J Thromb Haemost"},{"key":"9_CR28","doi-asserted-by":"crossref","unstructured":"Sevenet PO, Depasse F (2017) Clot waveform analysis: where do we stand in 2017? Int J Lab Hematol 39:561\u2013568","DOI":"10.1111\/ijlh.12724"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1046\/j.1365-2141.1997.1062972.x","volume":"98","author":"C Downey","year":"1997","unstructured":"Downey C, Kazmi R, Toh CH (1997) Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br J Haematol 98:68\u201373","journal-title":"Br J Haematol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"107602962091202","DOI":"10.1177\/1076029620912027","volume":"26","author":"H Wada","year":"2020","unstructured":"Wada H, Matsumoto T, Ohishi K, Shiraki K, Shimaoka M (2020) Update on the clot waveform analysis. Clin Appl Thromb Hemost 26:1076029620912027","journal-title":"Clin Appl Thromb Hemost"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/107602960601200206","volume":"12","author":"T Matsumoto","year":"2006","unstructured":"Matsumoto T, Wada H, Nishioka Y, Nishio M, Abe Y, Nishioka J, Kamikura Y, Sase T, Kaneko T, Houdijk WP, Nobori T, Shiku H (2006) Frequency of abnormal biphasic aPTT clot waveforms in patients with underlying disorders associated with disseminated intravascular coagulation. Clin Appl Thromb Hemost 12:185\u2013192","journal-title":"Clin Appl Thromb Hemost"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/1076029617724230","volume":"24","author":"T Matsumoto","year":"2018","unstructured":"Matsumoto T, Wada H, Fujimoto N, Toyoda J, Abe YMR, Ohishi K, Yamashita Y, Ikejiri M, Hasegawa K, Suzuki K, Imai H, Nakatani K, Katayama N (2018) An evaluation of the activated partial thromboplastin time waveform. Clin Appl Thromb Hemost 24:764\u2013770","journal-title":"Clin Appl Thromb Hemost"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","volume":"32","author":"K Bakhtiari","year":"2004","unstructured":"Bakhtiari K, Meijers JC, de Jonge E, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416\u20132421","journal-title":"Crit Care Med"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"14186","DOI":"10.1038\/s41598-020-71063-1","volume":"10","author":"CW Tan","year":"2020","unstructured":"Tan CW, Wong WH, Cheen MHH, Chu YMH, Lim SS, Ng LCK, Yeo DGD, Morvil G, Lee LH, Ng HJ (2020) Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections. Sci Rep 10:14186","journal-title":"Sci Rep"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3175-1_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:04:37Z","timestamp":1684479877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3175-1_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631744","9781071631751"],"references-count":34,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"20 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}